Comparison of Machine Learning Models for the Androgen Receptor.

Journal: Environmental science & technology
PMID:

Abstract

The androgen receptor (AR) is a target of interest for endocrine disruption research, as altered signaling can affect normal reproductive and neurological development for generations. In an effort to prioritize compounds with alternative methodologies, the U.S. Environmental Protection Agency (EPA) used data from 11 assays to construct models of AR agonist and antagonist signaling pathways. While these EPA ToxCast AR models require data to assign a bioactivity score, Bayesian machine learning methods can be used for prospective prediction from molecule structure alone. This approach was applied to multiple types of data corresponding to the EPA's AR signaling pathway with proprietary software, Assay Central. The training performance of all machine learning models, including six other algorithms, was evaluated by internal 5-fold cross-validation statistics. Bayesian machine learning models were also evaluated with external predictions of reference chemicals to compare prediction accuracies to published results from the EPA. The machine learning model group selected for further studies of endocrine disruption consisted of continuous AC data from the February 2019 release of ToxCast/Tox21. These efforts demonstrate how machine learning can be used to predict AR-mediated bioactivity and can also be applied to other targets of endocrine disruption.

Authors

  • Kimberley M Zorn
    Collaborations Pharmaceuticals, Inc. , 840 Main Campus Drive, Lab 3510 , Raleigh , North Carolina 27606 , United States.
  • Daniel H Foil
    Department of Chemistry and Biochemistry , University of North Carolina at Greensboro , Greensboro , NC 27402 , USA.
  • Thomas R Lane
    Collaborations Pharmaceuticals, Inc. , Main Campus Drive, Lab 3510 , Raleigh , North Carolina 27606 , United States.
  • Wendy Hillwalker
    Global Product Safety, SC Johnson and Son, Inc., Racine, Wisconsin 53404, United States.
  • David J Feifarek
    Global Product Safety, SC Johnson and Son, Inc., Racine, Wisconsin 53404, United States.
  • Frank Jones
    Global Product Safety, SC Johnson and Son, Inc., Racine, Wisconsin 53404, United States.
  • William D Klaren
    Global Product Safety, SC Johnson and Son, Inc., Racine, Wisconsin 53404, United States.
  • Ashley M Brinkman
    Global Product Safety, SC Johnson and Son, Inc., Racine, Wisconsin 53404, United States.
  • Sean Ekins
    Collaborations in Chemistry, 5616 Hilltop Needmore Road, Fuquay-Varina, NC 27526, USA; Collaborative Drug Discovery, 1633 Bayshore Highway, Suite 342, Burlingame, CA 94010, USA; Collaborations Pharmaceuticals, Inc., 5616 Hilltop Needmore Road, Fuquay-Varina, NC 27526, USA; Phoenix Nest, Inc., P.O. Box 150057, Brooklyn, NY 11215, USA; Hereditary Neuropathy Foundation, 401 Park Avenue South, 10th Floor, New York, NY 10016, USA. Electronic address: ekinssean@yahoo.com.